March 3rd, 2026: Federal Judge Appoints Leadership for GLP1 Vision Loss Lawsuits Multiple lawsuits alleging vision loss from GLP1 drugs, including Ozempic, Wegovy, and Mounjaro have been consolidated into a multidistrict litigation in the Eastern District of Pennsylvania, the same court responsible for handling GLP-1 lawsuits involving gastrointestinal injuries
Roy S, Malone S, Grimes S, Morgan SC
e , SMART1 inhibited Smurf1 protein level and PDK1 neddylation in cells (Smurf1-L: 0.5 M, SMART1Et: 0.5 M or SMART1: 0.5 M)
As displayed on the company website on December 26, 2025, multi-pack pricing ranged from $27.99$44.99 per pack depending on quantity, drawing interest from those seeking non-prescription alternatives